It looks like there might be differences between controller immune systems and regular ones that don't have to do with choice of epitope:
http://jid.oxfordjournals.org/content/early/2013/12/19/infdi...
Does this make it less likely that targeting specific epitopes is all there is to the picture? (I'm happy to assume that we'll get an immune response with memory in humans -- the question is, how confident should we be that that response will control HIV?)